Diagnostic Value Analysis of PI-RADS v2.1 Combined with ADC Values in the Risk Stratification of Prostate Cancer Gleason Scores: A Retrospective Study
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Combining Prostate Imaging Reporting and Data System (PI-RADS) v2.1 scores with apparent diffusion coefficient (ADC) values improves prostate cancer risk stratification. This imaging approach offers high accuracy for Gleason risk grading, aiding treatment decisions.
Area Of Science
- Radiology and Oncology
- Medical Imaging
- Prostate Cancer Diagnostics
Background
- Prostate cancer necessitates precise risk stratification for effective management.
- Current methods require enhancement for improved accuracy in predicting patient outcomes.
- Imaging plays a crucial role in advancing prostate cancer assessment.
Purpose Of The Study
- To evaluate the diagnostic efficacy of PI-RADS v2.1 scores and ADC values in prostate cancer risk stratification.
- To determine the combined predictive value of PI-RADS v2.1 and ADC for Gleason risk grading.
- To assess the utility of imaging biomarkers in clinical decision-making for prostate cancer.
Main Methods
- Retrospective analysis of clinical data from 145 prostate cancer patients.
- Categorization of patients into low-moderate and high-risk groups based on Gleason scores.
- Assessment of PI-RADS v2.1 scores and calculation of ADC values using diffusion-weighted imaging.
- Statistical analyses including logistic regression and ROC curve analysis.
Main Results
- Significant differences in PI-RADS v2.1 scores and ADC values were observed between risk groups (p < 0.001).
- Mean ADC showed high sensitivity (0.912) and AUC (0.962).
- The combination of PI-RADS v2.1 and mean ADC demonstrated superior predictive value (AUC = 0.966) for Gleason risk grading.
Conclusions
- PI-RADS v2.1 combined with ADC values significantly enhances the accuracy of prostate cancer risk stratification.
- This combined imaging approach shows strong potential for improving Gleason risk grading.
- The findings support the utility of advanced imaging techniques in prostate cancer management.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
